Gilead Sciences, Inc. vs Under Armour Inc Class A — how do they compare? Gilead Sciences, Inc. trades at $135.5 (market cap $168.35B), while Under Armour Inc Class A trades at $5.38 (market cap $2.26B). The key difference: Gilead Sciences, Inc. is far larger — about 74.5× Under Armour Inc Class A's market cap, and Gilead Sciences, Inc. pays a 2.42% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.
| GILD | UAA | |
|---|---|---|
Market Cap | $168.35B | $2.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $155.80 | $8.14 |
52-Week Low | $110.56 | $4.17 |
Enterprise Value | $191.42B | $3.24B |
Dividend Yield | 2.42% | — |
Trailing returns across standard periods
Latest headlines on both assets
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →